Stocks
JPMorgan Raises Omada Health Target Price to $30.00 Amid Bullish Analyst Sentiment
Omada Health (NASDAQ:OMDA), a digital health company focused on chronic condition prevention and management, has seen its target price lifted by JPMorgan Chase & Co. from $26.00 to $30.00 in a research report issued on Friday.
The brokerage currently has an 'overweight' rating on the stock, indicating a potential upside of 23.85% from its current price.
Other analysts have also weighed in on Omada Health, with Barclays lifting their target from $20.00 to $25.00 and giving the company an 'overweight' rating, while Evercore reiterated an 'outperform' rating and target of $20.00.